Q2P-12234-22030
4 vaccinations
1 coded response
41 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 669 / KS
- Registered
- 2020-12-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-17
Dose 1 — Pfizer-BioNTech
-
2020-12-20
Registered in v-safe
- 2020-12-20
-
2020-12-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness · Muscle or body achesAdult check-in
-
2020-12-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness · Muscle or body achesAdult check-in
-
2020-12-24
Health check-in — day 7, dose 1Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-24
Report sent to call center — day 7, dose 1Be unable to do your normal daily activities1 call case(s)
- 2020-12-31
-
2021-01-07
Dose 2 — Pfizer-BioNTech
- 2021-01-07
-
2021-01-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-21
- 2021-01-28
-
2021-02-04
Survey response — day 28, dose 2MedDRA: Diarrhoea, Pyrexia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: DiarrheaBrief feverMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-11
- 2021-02-18
- 2021-04-08
- 2021-07-08
-
2021-09-10
Dose 3 — Pfizer-BioNTech
- 2021-09-28
- 2021-10-01
- 2021-10-08
- 2021-10-15
- 2021-10-22
- 2021-12-10
- 2022-03-11
-
2022-06-24
Dose 4 — Pfizer-BioNTech
-
2022-06-26
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Redness · Fever · Headache, Fatigue or tirednessAdult check-in
- 2022-06-27
- 2022-06-28
- 2022-06-29
- 2022-06-30
- 2022-07-01
- 2022-07-08
- 2022-07-15
- 2022-07-22
- 2022-07-29
- 2022-08-05
- 2022-09-23
- 2022-12-23
- 2023-06-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech | |
| 3 | 2021-09-10 | Pfizer-BioNTech | No |
| 4 | 2022-06-24 | Pfizer-BioNTech | No |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 3 — day 28, dose 2
Symptoms: DiarrheaBrief fever
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release